Login
Related Links
NewScientist Gene Therapy jobs - Location Worldwide
- Barts Cancer Institute , Queen Mary University London: Postdoctoral Research Assistant Sat, 12 Oct 2024 00:00:00 +0000
£ 39,065 - £43,305 per annum: Barts Cancer Institute , Queen Mary University London: Postdoctoral Research Assistant About the Role A Postdoctoral Research Assistant to undertake research into the development of viro-immunotherapy fo London, United Kingdom - The Francis Crick Institute: Postdoctoral Fellow â In Vivo Wed, 25 Sep 2024 16:04:00 +0000
From £43,210, subject to skills and experience, with benefits: The Francis Crick Institute: This project aims to determine the host and viral factors that drive persistent infection London (Central), London (Greater) - The Francis Crick Institute: Postdoctoral Fellow - Molecular Wed, 25 Sep 2024 15:56:00 +0000
From £43,210, subject to skills and experience, with benefits: The Francis Crick Institute: A potential project is to explore the molecular basis of RNA virus replication, focusing on viral genome transcription, replication, and packaging London (Central), London (Greater) - The Francis Crick Institute: Postdoctoral Fellow - Znamenskiy lab Mon, 16 Sep 2024 11:40:00 +0000
From £43,210 with benefits, subject to skills and experience: The Francis Crick Institute: The Znamenskiy lab studies the relationship between in vivo function, synaptic organization, and molecular identity of cortical neurons. London (Central), London (Greater) - CK Group: QA Manager Tue, 08 Oct 2024 10:41:00 +0000
Competitive: CK Group: CK Group are recruiting for a QA Manager on behalf of a growing Cell Therapy CDMO, to lead the establishment of a quality framework for... Cambridge - CK Group: QA Manager Tue, 08 Oct 2024 10:36:00 +0000
£85000 - £100000 per annum: CK Group: CK Group are recruiting for a QA Manager on behalf of a growing Cell Therapy CDMO, to lead the establishment of a quality framework for... Cambridge - Oxford Nanopore Technologies: Senior Director Regulatory Affairs Mon, 30 Sep 2024 09:21:00 +0000
Negotiable: Oxford Nanopore Technologies: About Us Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and commercial presence Oxford, England - Oxford Nanopore Technologies: Senior Director Regulatory Affairs Fri, 20 Sep 2024 12:00:00 +0000
Negotiable: Oxford Nanopore Technologies: About Us Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and commercial presence Oxford, England - SGS: Molecular Biology QC Analyst Sat, 12 Oct 2024 00:00:00 +0000
Competitive: SGS: Company Description As a global leader in sustainability, quality, and integrity, our 99,600-strong workforce across 2,600 offices and labs is dedica Glasgow, United Kingdom - King's College London: Post-doctoral Research Associate Fri, 11 Oct 2024 00:00:00 +0000
Competitive: King's College London: About us The School of Cardiovascular and Metabolic Medicine & Sciences (SCMMS), is one of six schools in the Faculty of Life Sciences & Medicine (F London, United Kingdom
RSS Source >> View more gene therapy jobs at NewScientist Jobs
Gene Therapy Jobs Info
Selection of latest gene therapy jobs found at NewScientist Jobs by using the keywords: "gene therapy" OR "gene targeting" OR "gene delivery" OR "viral vector"
To advertise your vacancies here, please use the contact form.
More gene therapy jobs and career oppertunities:
To advertise your vacancies here, please use the contact form.
More gene therapy jobs and career oppertunities:
ASGCT Job Bank | |
ESGCT Job postings | |
BSGCT Job list | |
NewScientist Jobs | |
PostdocJobs.com | |
MySpace.com Jobs | |
Jooble Science Jobs |
Gene Therapy News
- AaviGen, SK pharmteco Announce Manufacturing Agreement for Heart Failure Gene Therapy - BioPharm International
Sat, 12 Oct 2024 17:37:1 GMT - HNSA-5487 Significantly Reduces IgG Levels, FDA Removes Hold on AOC 1001, DMD Gene Therapy Shows No Impact on Cardiac Outcomes - Neurology Live
Sat, 12 Oct 2024 13:09:1 GMT - Gene therapy benefits boys with rare brain disease, but hematologic cancer remains a risk - Healio
Fri, 11 Oct 2024 17:30:2 GMT - Fierce Pharma Asia—AstraZeneca-CSPC heart med deal; Astellas' gene therapy pact, new cell therapy site - FiercePharma
Fri, 11 Oct 2024 15:48:5 GMT - Worries Mount Over Cancer Risks in Bluebird Bio's Gene Therapy - Benzinga
Fri, 11 Oct 2024 15:09:1 GMT - Buy, Sell, Hold: Cell and Gene Therapy - Pharmaceutical Technology Magazine
Fri, 11 Oct 2024 13:01:3 GMT - Magnetically regulated gene therapy tech offers precise brain-circuit control - Medical Xpress
Thu, 10 Oct 2024 20:25:0 GMT - Hubble Therapeutics Taps Andelyn to Manufacture Clinical Grade AAV for Eye Disorder Gene Therapy - Genetic Engineering & Biotechnology News
Thu, 10 Oct 2024 19:29:0 GMT - Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials - Yahoo Finance
Thu, 10 Oct 2024 19:22:1 GMT - Bluebird bio’s Skysona led to seven cases of blood cancer in gene therapy trials - Pharmaceutical Technology
Thu, 10 Oct 2024 18:24:3 GMT - Report gives update on boys with rare brain disease 6 years after gene therapy - UPI News
Thu, 10 Oct 2024 16:10:4 GMT - Sarepta’s gene therapy is fully approved, but its stock has tanked. Here’s why - STAT
Thu, 10 Oct 2024 16:02:5 GMT - Magnetically Regulated Gene Therapy Tech Offers Precise Brain-Circuit Control - Weill Cornell Medicine Newsroom
Thu, 10 Oct 2024 15:33:5 GMT - 7 Children Receiving Bluebird’s Gene Therapy Developed Blood Cancers: Study - BioSpace
Thu, 10 Oct 2024 15:18:5 GMT - Highly targeted approach supports ALS gene therapy development - ALS News Today
Thu, 10 Oct 2024 15:14:0 GMT